⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RYTM News
Rhythm Pharmaceuticals, Inc. Common Stock
Señorita Broadens Portfolio With 1777, the Brand’s First Non-Alcoholic THC Spirit
globenewswire.com
RYTM
Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
globenewswire.com
RYTM
Introducing Peanut Buddah Cups, A New and Nutty THC Treat From incredibles
globenewswire.com
RYTM
Form 8-K
sec.gov
RYTM
Rhythm Pharmaceuticals Announces Changes to Board of Directors
globenewswire.com
RYTM
Form 8-K
sec.gov
RYTM
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment
globenewswire.com
RYTM
PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
prnewswire.com
RYTM
Form 8-K
sec.gov
RYTM
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
globenewswire.com
RYTM